"Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by Medical ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Nasdaq chair and CEO Adena Friedman is still a believer in DEI initiatives, and in the IPO market coming back.

When it comes to stock market debuts, 2024 was not an active year for many industries, not least cross-border payments, but ...

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its ...

Some of the most high-profile names that are likely to headline this year's IPO market resurgence include Swedish payments ...

Shares surged through the $40 level as the stock gained another 20%. Nano Nuclear shares are now trading 75& higher in 2025 ...

Nasdaq CEO Adena Friedman is optimistic that President Trump's administration will offer a chance to relook regulations in ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Even as FIIs consider valuations in the secondary market high, they remain upbeat on India's market narrative, compelling them to seize every opportunity, say experts.

Rashaun Williams, Atlanta Falcons limited partner and venture capitalist, joined "Closing Bell" on CNBC to discuss his investment strategy and his outlook on the IPO market as 2025 ...